Category: Legal
Legal
The U.S. Attorney for Massachusetts issues a "civil investigative demand" for documents on Medtronics' CoreValve subsidiary and its relationship to the Lahey Clinic in a false claims investigation.
It's shaping up to be a tough day for Medtronic Inc. (NYSE:MDT), as news of a federal false claims investigation follows questions from the Food & Drug Administration about a study of one of its deep-brain stimulation devices.
The Fridley, Minn.-based medical devices monolith revealed in a March 10 securities filing that the U.S. Attorney for Massachusetts issued a "civil investigative demand" Feb. 22 for documents in a false claims probe into the relationship of its CoreValve subsidiary with the Burlington, Mass.-based Lahey Clinic, "specifically relating to cardiologists at the clinic, CoreValve Inc. ... and the Lahey Clinic, and certain employees of both [Medtronic] and the clinic, among other topics."
Johnson & Johnson isn't the only party appealing a Delaware judge's ruling that four of its patents are invalid, as Boston Scientific Corp. cross-appeals despite winning the case's last round.
Boston Scientific Corp. (NYSE:BSX) may have won the most recent round in its stent patents war with Johnson & Johnson (NYSE:JNJ), but that didn't stop the Natick, Mass.-based devices giant from cross-appealing a Delaware judge's ruling.
The patents in question are at the heart of complicated legal wrangling involving Boston Scientific, its New Brunswick, N.J.-based rival and competitor/partner Abbott (NYSE:ABT). The dispute centers around Boston Scientific's Promus stent, a private-label version of Abbott's Xience V stent, and the JNJ subsidiary Cordis Corp.'s Cypher.
Caliper Life Sciences Inc. sues Carestream Health Inc., accusing it of infringing a suite of seven diagnostics imaging patents it licenses from Stanford University.
Caliper Life Sciences Inc. (NSDQ:CALP) sued Carestream Health Inc., accusing the Rochester, N.Y.-based company of violating a suite of seven diagnostics imaging patents Caliper licenses from Stanford University.
The lawsuit, filed in the U.S. District Court for Eastern Texas, alleges that Carestream's In-Vivo Molecular Imaging Solutions and Image Station Molecular Imaging Solutions lines, including a series of Kodak-brand devices Carestream acquired from Eastman Kodak Co. in 2007, infringes the patents covering Caliper subsidiary Xenogen Corp.'s IVIS imaging system. The IVIS devices are used for preclinical non-invasive imaging of mammals covered by the Caliper patents.
A federal judge denied Johnson & Johnson's bid to revive its $5.5 billion anti-competition and breach of contract lawsuit against Boston Scientific Corp. and Abbott over its abortive attempt to acquire Guidant Corp. in 2005.
Boston Scientific Corp. (NYSE:BSX) got some rare good news in connection with its infamous acquisition of Guidant Corp. when a federal judge denied a bid by Johnson & Johnson (NYSE:JNJ) to revive a $5.5 billion lawsuit against BSX and Abbott (NYSE:ABT) over the Guidant buyout.
Johnson & Johnson appeals a federal court's ruling that four of its Cordis Corp. stent patents are invalid in an infringement case against Boston Scientific.
Johnson & Johnson (NYSE:JNJ) appealed a federal judge's ruling that four of its Cordis Corp. subsidiary's drug-eluting stent patents are invalid, the latest salvo in its long-running infringement battle with Boston Scientific Corp. (NYSE:BSX).
The patents in question are at the heart of complicated legal wrangling involving the Natick, Mass.-based medical device giant, its New Brunswick, N.J.-based rival and its competitor/partner Abbott (NYSE:ABT). The dispute centers around Boston Scientific's Promus stent, a private-label version of Abbott's Xience V stent, and the Cordis Cypher.
The U.S. Court of Appeals for the Ninth Circuit upholds a lower court's ruling absolving Johnson & Johnson subsidiary DePuy Spine of any liability for one of its spinal disc implants.
The U.S. Court of Appeals for the Ninth Circuit handed a victory to DePuy Spine Inc. in a product liability lawsuit over one of its spinal disc implants.
Camille Carson sued the Raynham, Mass.-based Johnson & Johnson (NYSE:JNJ) subsidiary in 2006, after a February 2005 discectomy procedure to replace two of her vertebral discs with DePuy Charite implants. Experiencing extreme pain a few months after the surgery, Carson had a second procedure in November 2005 which revealed that one of the Charite discs was broken and had to be removed in pieces, according to court documents. Carson accused the company of being liable for manufacturing a defective product and for promoting the off-label use of the device.
A jury in Texas awarded Smith & Nephew $4.7 million and ruled that Arthrex Inc. infringed a patent related to its EndoButton knee fixation device.
A jury in Texas ruled that Arthrex Inc. infringed a patent held by Smith & Nephew Inc. (NYSE:SNN) and awarded a $4.7 million judgment to the British medical device giant.
Smith & Nephew's Andover, Mass.-based endoscopy division sued Naples, Fla.-based Arthrex in 2007 in the United States District Court for Eastern Texas, accusing it of violating a pair of patents covering techniques for attaching anterior cruciate ligament grafts to bone. The companies agreed to dismiss the charges relating to one of the patents, according to court documents, but allowed a jury to decide about the other patent.
